Archive for October 2020
AiViva BioPharma Initiates Phase 1/2 Clinical Trial of AIV001 for Nonmelanoma Skin Cancer
NEWPORT BEACH, Calif., October 2, 2020 (GLOBE NEWSWIRE) – AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has begun dosing patients diagnosed with superficial or nodular basal cell…
Read More